Clinical Trial - Trial KCT0008025
Access comprehensive clinical trial information for KCT0008025 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by National Cancer Center and is currently Not yet recruiting. The study focuses on gastric cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Korean Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
KCT0008025
Phase 1/2
Not yet recruiting
Trial Details
Korean Clinical Trial Registry • KCT0008025
Untitled Trial
Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer and the companion diagnostic development
Study Focus
Interventional
Sponsor & Location
National Cancer Center
South Korea
Timeline & Enrollment
Phase 1/2
N/A
N/A
ICD-10 Classifications
Gastric ulcer
Malignant neoplasm of stomach
Malignant neoplasm: Body of stomach
Carcinoma in situ: Stomach
Malignant neoplasm: Stomach, unspecified
Data Source
Korean Clinical Trial Registry
KCT0008025
Non-Device Trial